IBA

Companies IBA

IBA GmbH, Germany

IBA GmbH – Solutions For Life Sciences Being one of the foremost providers of tag-derived products and services IBA GmbH is covering the entire production process of recombinant proteins including cloning, transfection, protein expression and purification to detection, assay and immobilization. "S more

Products IBA

StarGate - the new dimension in combinatorial cloning

StarGate offers simple, rapid and highly efficient simultaneous subcloning of an arbitrary gene in up to 150 different Expression Vectors (Acceptor Vectors). Thus StarGate offers for a multitude of applications, like e.g. protein expression, protein:protein interaction studies or HTS the optimal solution more

News IBA

• IBA and Bayer Schering Pharma Sign Clinical Trial Supply Agreement for Alzheimer’s Disease Tracer

  IBA (Ion Beam Applications S.A.) announced that they have entered into an agreement with Bayer Schering Pharma AG, Germany (Bayer) for chemical process development and clinical trial doses supply of FLORBETABEN, a molecular imaging compound in development for the detection of Alzheimer’s Disease pat more

• Wilex' REDECTANE meets both endpoints specificity and sensitivity with superiority over CT in its pivotal Phase III trial

  WILEX AG and IBA (Ion Beam Applications SA) announced that the final results of the pivotal phase III registration trial REDECT have been received. The results of the study demonstrate that PET/CT with REDECTANE(R) lead to a significantly improved diagnosis in comparison to CT alone. The aim of the more

• IBA announces its partnership with Beckman Coulter for the distribution of IBA's Streptamer product portfolio

  IBA GmbH and Beckman Coulter, Inc. have agreed to a partnership for the distribution of IBA's Streptamer® products. With this partnership, IBA provides Beckman Coulter with exclusive distribution rights for IBA´s proprietary Streptamer technology in North America and co-exclusive distribution rights more

Publications IBA

• Design, Synthesis and Evaluation of Indolebutylamines as a Novel Class of Selective Dopamine D3 Receptor Ligands

  A series of indolebutylamine (IBA) derivatives were designed, synthesized and evaluated as a novel class of selective ligands for the dopamine 3 receptor (D3R). The most potent compound 11q binds to D3R with a Ki value of 124 nM and displays excellent selectivity over the dopamine 1 receptor (D1R) more

• Micropropagation of seedless lemon (Citrus limon L. cv. Kaghzi Kalan) and assessment of genetic fidelity of micropropagated plants using RAPD markers

  A micropropagation protocol was developed for multiplication of seedless lemon (Citrus limon L. cv. Kaghzi Kalan) using nodal explants. The maximum shoot regeneration was observed on low level of BAP (0.1 mg l−1) or kinetin (0.5 mg l−1). BA was recorded to be better than kinetin in terms of number o more

• Micropropagation of annatto (Bixa orellana L.) from mature tree and assessment of genetic fidelity of micropropagated plants with RAPD markers

  An in vitro propagation technique based on axillary bud proliferation was developed for the first time to mature annatto (Bixa orellana L.) tree. Nodal segments cultured on Murashige and Skoog (MS) medium supplemented with 1.0 μM benzyl adenine (BA) and tender coconut water (10 %) showed significant more

Market studies IBA

• Global Radiation Oncology Market 2011-2015

  TechNavio's analysts forecast the Global Radiation Oncology market to grow at a CAGR of 7.9 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing prevalence of cancer. The Global Radiation Oncology market has also been witnessing the trend of more

• iSOFT Group PLC - Strategic SWOT Analysis Review

  iSOFT Group plc (iSOFT) is a Healthcare Information Technology company and a part of IBA Health Group. The company is engaged in the design, development and marketing of advanced software applications for the healthcare market. Its applications track patient records and handle accounting and managem more

• Belgium Pharmaceuticals and Healthcare Report Q3 2011

  BMI View: Belgium’s pharmaceutical market is small in absolute size, but compares favourably with other Western European markets in terms of per-capita expenditure. High value patented medicines dominate the market and account for around three-quarters of sales by value. Belgium is home to a number more

Websites IBA